Device Trial Radar · NCT02514525
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Mar 2016
Primary completion
Mar 2024
Study completion Dec 2025
Sponsor
- Lead sponsor
- Pentax MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 3, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") Barrett's Esophagus (BE)
Conditions
- Barrett Esophagus
Interventions
CryoBalloon Ablation SystemDevice
CryoBalloon Ablation System, a balloon-based cryotherapy device, provides controlled ablation for the treatment of BE. Deployed through the working channel of an endoscope, the Balloon is simultaneously inflated and cooled with an inert cryogen (nitrous oxide) delivered from the handle that ablates the BE cells upon contact with the esophagus.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of serious, CryoBalloon Ablation System-related adverse eventsTime frame: 12 months
3 more outcomes with a free account
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
UC Irvine
Orange, California
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.